None listed
Conditions
Interventions
Intervention1: Dexmedetomidine: In this group the participants will receive dexmedetomidine 0.5mcg/kg diluted to 20 ml NS over 10 minutes 15 minutes prior to extubation.
Control Intervention1: Clonidi
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: All ASA 1 patients between the age of 6 months and 6 years coming for palatoplasty surgery whose parents are willing to give consent will be enrolled.
Exclusion criteria
Exclusion criteria: Parentâ??s refusal to consent, ASA 2 or above, upper respiratory tract infection, cardiac abnormality, major other systemic illness, coagulopathy, known allergy to alpha agonist agents will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparing incidence of emergence agitation of dexmedetomidine with clonidineTimepoint: Emergence agitation will be assessed with FLACC score and Pediatric Anesthesia Emergence Delirium Scale every 5 min from the time of shifting to PACU until discharged | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of FLACC score, PAED scale, time to discharge in PACU, amount of rescue analgesics needed in PACUTimepoint: Emergence agitation will be assessed with FLACC score and Pediatric Anesthesia Emergence Delirium Scale every 5 min from the time of shifting to PACU until discharged | — |
Countries
India
Contacts
Public ContactGraceline Vandana Nickelson
Christian Medical College, Vellore.
Outcome results
None listed